01 1Aurobindo Pharma Limited
01 1ELETRIPTAN HYDROBROMIDE
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2017-02-28
Pay. Date : 2017-01-19
DMF Number : 31336
Submission : 2017-01-21
Status : Active
Type : II
20
Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ELETRIPTAN HYDROBROMIDE, with a corresponding US DMF Number 31336.
Remarkably, this DMF maintains an Active status since its submission on January 21, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 28, 2017, and payment made on January 19, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II
